A detailed history of Jane Street Group, LLC transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 25,065 shares of MAIA stock, worth $83,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,065
Holding current value
$83,466
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.1 - $2.55 $27,571 - $63,915
25,065 New
25,065 $55,000
Q3 2022

Nov 14, 2022

BUY
$3.25 - $7.8 $33,182 - $79,638
10,210 New
10,210 $34,000

Others Institutions Holding MAIA

About MAIA Biotechnology, Inc.


  • Ticker MAIA
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,935,900
  • Market Cap $36.4M
  • Description
  • MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...
More about MAIA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.